Park Avenue Securities’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
12,572
+345
+3% +$35.7K 0.01% 848
2026
Q1
$1.18M Buy
12,227
+2,474
+25% +$254K 0.01% 742
2025
Q4
$1.03M Sell
9,753
-158
-2% -$18.3K 0.01% 794
2025
Q3
$1.26M Buy
9,911
+758
+8% +$90.2K 0.01% 782
2025
Q2
$1.12M Buy
9,153
+2,030
+28% +$232K 0.01% 740
2025
Q1
$721K Buy
7,123
+386
+6% +$37.7K 0.01% 721
2024
Q4
$622K Buy
6,737
+2,082
+45% +$204K 0.01% 973
2024
Q3
$450K Sell
4,655
-969
-17% -$87.1K 0.01% 1014
2024
Q2
$482K Buy
5,624
+194
+4% +$16.3K 0.01% 989
2024
Q1
$448K Sell
5,430
-148
-3% -$10.8K 0.01% 1012
2023
Q4
$372K Buy
5,578
+1,144
+26% +$74.1K 0.01% 1030
2023
Q3
$298K Buy
+4,434
New +$305K ﹤0.01% 1051
2023
Q1
Sell
-3,723
Closed -$223K 830
2022
Q4
$223K Buy
+3,723
New +$202K ﹤0.01% 1102
2022
Q3
Sell
-4,804
Closed -$214K 1127
2022
Q2
$214K Buy
4,804
+593
+14% +$30.4K ﹤0.01% 1041
2022
Q1
$238K Buy
+4,211
New +$220K ﹤0.01% 1034
2021
Q4
Sell
-3,956
Closed -$236K 1112
2021
Q3
$236K Buy
+3,956
New +$249K ﹤0.01% 943

Other funds holding EHC

Park Avenue Securities's EHC Position: Q2 2026 in Review

Park Avenue Securities increased its Encompass Health (EHC) stake by 2.8% in Q2 2026, buying an estimated $35.7K and bringing the position to 12,572 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #848.

Park Avenue Securities first reported a position in EHC in Q3 2021 and has held it in 16 quarters since. 81 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Park Avenue Securities held 12,572 shares of Encompass Health worth $1.27M as of Q2 2026.
  • Park Avenue Securities bought 345 Encompass Health shares in Q2 2026, an estimated $35.7K.
  • Encompass Health made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #848 holding.
  • Park Avenue Securities first reported a position in Encompass Health in Q3 2021 and has held it in 16 quarters since.
  • 81 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.